|
⚲
|
| Keyboard |
| Sandman Paul W
✚
|
|
|---|---|
| CIK # | 0001191251 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001191251] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sandman Paul W | |
| PDL Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PDL Biopharma Inc PDLI
Stock Option (right to buy) · derivative
|
2019-06-20 | Grant | 126,050 | $3.00 | 378,150 |
|
PDL Biopharma Inc PDLI
Common stock
|
2018-06-08 | Grant | 54,348 | $2.76 | 150,000 |
|
PDL Biopharma Inc PDLI
Common stock
|
2017-06-09 | Grant | 60,729 | $2.47 | 150,001 |
|
PDL Biopharma Inc PDLI
Common stock
|
2016-06-02 | Grant | 71,023 | $3.52 | 250,001 |
|
PDL Biopharma Inc PDLI
Common stock
|
2015-05-28 | Grant | 22,059 | $6.80 | 150,001 |
|
PDL Biopharma Inc PDLI
Common stock
|
2014-05-28 | Grant | 5,371 | $9.31 | 50,004 |
|
PDL Biopharma Inc PDLI
Common stock
|
2013-05-21 | Grant | 5,974 | $8.37 | 50,002 |
|
PDL Biopharma Inc PDLI
Common Stock
|
2012-06-05 | Grant | 7,924 | $6.31 | 50,000 |